SEC Form 4 · accession 0001437749-17-002389
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles K Dargan
Officer — Chief Financial Officer
Period of report
Feb 10, 2017
Accepted (ET)
Feb 14, 2017 · 2:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option AgreementF2,F1 | $0.69 | Feb 10, 2017 | A | 300,000 | A | Feb 10, 2017 | Feb 10, 2027 | Common Stock | 300,000 | 2,746,000 | D |
Explanation of responses
- F1The Option is exercisable according to its vesting schedule: (i) 125,000 shares on February 10, 2017, and then (ii) in equal monthly installments of 25,000 shares beginning March 1, 2017, so long as the Engagement Extension Agreement dated February 10, 2017, between Reporting Owner and Issuer remains in force and effect.
- F2This Option was issued to the Reporting Person as the sole compensation to serve as Issuer's Chief Financial Officer from for a one year period ending September 30, 2017.